This post was originally published on Medscape
You will shortly be re-directed to the publisher's website
A new analysis of BP products and benzene degradation finds that formulation matters, with leave-on products having lower benzene, and levels ‘unlikely to be a clinically meaningful issue,’ a researcher said.
Medscape Medical News